ENTX · Categories · Form 4

ENTX - SEC Form 4 insider transactions

Entera Bio Ltd. (ENTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ENTX

• 18d
  Director Rubin Steven D was granted 19,117 units of Ordinary Shares, increasing direct ownership by 127% to 34,117 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 18d
  Director Malca Yonatan was granted 22,815 units of Ordinary Shares, increasing direct ownership by 29% to 100,231 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 18d
  Director Taitel Haya was granted 20,790 units of Ordinary Shares, increasing direct ownership by 21% to 119,269 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 18d
  Director Ellis Sean was granted 20,034 units of Ordinary Shares, increasing direct ownership by 11% to 208,132 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 18d
  SEC Form 4 filed by Chief Financial Officer Yaacov-Garbeli Dana

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 18d
  SEC Form 4 filed by Chief Operating Officer Galitzer Hillel

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 18d
  SEC Form 4 filed by Chief of R&D Burshtein Gregory

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 18d
  SEC Form 4 filed by Chief Executive Officer Toledano Miranda Jayne

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 18d
  Director Germano Geno J was granted 25,014 units of Ordinary Shares, increasing direct ownership by 63% to 65,014 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 40d
  Chief Executive Officer Toledano Miranda Jayne was granted 420,560 units of Ordinary Shares, increasing direct ownership by 99% to 847,135 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 109d
  Chief Operating Officer Galitzer Hillel was granted 72,993 units of Ordinary Shares, increasing direct ownership by 81% to 163,566 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 109d
  Chief Financial Officer Yaacov-Garbeli Dana was granted 58,394 units of Ordinary Shares (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 109d
  Chief of R&D Burshtein Gregory was granted 87,591 units of Ordinary Shares, increasing direct ownership by 86% to 189,033 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 235d
  Director Ostrov Gerald M was granted 28,721 units of Ordinary Shares, increasing direct ownership by 61% to 75,657 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 235d
  Director Ellis Sean was granted 25,371 units of Ordinary Shares, increasing direct ownership by 19% to 160,098 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 235d
  Director Malca Yonatan was granted 30,157 units of Ordinary Shares, increasing direct ownership by 64% to 77,416 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 235d
  Director Lieberman Gerald M was granted 38,294 units of Ordinary Shares, increasing direct ownership by 13% to 338,454 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 235d
  Director Taitel Haya was granted 26,329 units of Ordinary Shares, increasing direct ownership by 41% to 90,979 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 403d
  Chief Executive Officer Toledano Miranda Jayne was granted 180,702 units of Ordinary Shares, increasing direct ownership by 77% to 415,575 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 403d
  Chief of R&D Burshtein Gregory was granted 26,316 units of Ordinary Shares, increasing direct ownership by 35% to 101,442 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 403d
  Chief Financial Officer Yaacov-Garbeli Dana was granted 26,316 units of Ordinary Shares (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 482d
  Chief Operating Officer Galitzer Hillel was granted 26,316 units of Ordinary Shares, increasing direct ownership by 41% to 90,573 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 509d
  Director Lieberman Gerald M exercised 23,952 units of Ordinary Shares at a strike of $1.00, increasing direct ownership by 9% to 300,160 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 585d
  Director Taitel Haya was granted 6,922 units of Ordinary Shares, increasing direct ownership by 12% to 64,650 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 585d
  Director Ostrov Gerald M was granted 8,038 units of Ordinary Shares, increasing direct ownership by 21% to 46,936 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 585d
  Director Malca Yonatan was granted 8,216 units of Ordinary Shares, increasing direct ownership by 21% to 47,259 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 585d
  Director Lieberman Gerald M was granted 10,717 units of Ordinary Shares, increasing direct ownership by 4% to 276,208 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 585d
  Director Ellis Sean was granted 7,100 units of Ordinary Shares, increasing direct ownership by 6% to 134,727 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 690d
  Director Taitel Haya was granted 7,278 units of Ordinary Shares, increasing direct ownership by 14% to 57,728 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 690d
  Director Ostrov Gerald M was granted 8,452 units of Ordinary Shares, increasing direct ownership by 28% to 38,898 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 690d
  Director Malca Yonatan was granted 8,639 units of Ordinary Shares, increasing direct ownership by 28% to 39,043 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 690d
  Director Lieberman Gerald M was granted 11,269 units of Ordinary Shares, increasing direct ownership by 4% to 265,491 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 690d
  Director Ellis Sean was granted 7,466 units of Ordinary Shares, increasing direct ownership by 6% to 127,627 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 726d
  Director Ostrov Gerald M was granted 20,446 units of Ordinary Shares, increasing direct ownership by 204% to 30,446 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 726d
  Director Taitel Haya was granted 15,335 units of Ordinary Shares, increasing direct ownership by 44% to 50,450 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 726d
  Director Ellis Sean was granted 18,061 units of Ordinary Shares, increasing direct ownership by 18% to 120,161 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 726d
  Director Malca Yonatan was granted 23,172 units of Ordinary Shares, increasing direct ownership by 320% to 30,404 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 726d
  Director Lieberman Gerald M was granted 27,261 units of Ordinary Shares, increasing direct ownership by 12% to 254,222 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 753d
  Amendment: Chief Financial Officer Yaacov-Garbeli Dana was granted 30,151 units of Ordinary Shares (SEC Form 4)

  4/A - Entera Bio Ltd. (0001638097) (Issuer)
• 753d
  Chief Executive Officer Toledano Miranda Jayne was granted 124,121 units of Ordinary Shares, increasing direct ownership by 112% to 234,873 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 854d
  Yaacov-Garbeli Dana was granted 30,151 units of Ordinary Shares, increasing direct ownership by 53% to 86,731 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 854d
  Galitzer Hillel was granted 30,151 units of Ordinary Shares, increasing direct ownership by 88% to 64,257 units (SEC Form 4)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 965d
  SEC Form 4 filed by Taitel Haya

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 965d
  SEC Form 4 filed by Garceau Roger

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 965d
  SEC Form 4 filed by Malca Yonatan

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 965d
  SEC Form 4 filed by Ostrov Gerald M

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 965d
  SEC Form 4 filed by Mayron Ron

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 965d
  SEC Form 4 filed by Lieberman Gerald M

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 965d
  SEC Form 4 filed by Ellis Sean

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1076d
  SEC Form 4 filed by Taitel Haya

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1076d
  SEC Form 4 filed by Toledano Miranda Jayne

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1097d
  SEC Form 4: Taitel Haya bought $11,216 worth of Ordinary Shares (18,000 units at $0.62)

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1098d
  SEC Form 4: Lieberman Gerald M bought $11,784 worth of Ordinary Shares (20,000 units at $0.59), increasing direct ownership by 10% to 214,209 units

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1099d
  SEC Form 4: Ellis Sean bought $24,000 worth of Ordinary Shares (40,000 units at $0.60), increasing direct ownership by 64% to 102,100 units

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1218d
  SEC Form 4 filed by Santora Arthur C Ii

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1218d
  SEC Form 4 filed by Yaacov-Garbeli Dana

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1218d
  SEC Form 4 filed by Galitzer Hillel

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1237d
  SEC Form 4 filed by Toledano Miranda Jayne

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1329d
  SEC Form 4 filed by Garceau Roger

  4 - Entera Bio Ltd. (0001638097) (Issuer)
• 1329d
  SEC Form 4 filed by Lieberman Gerald M

  4 - Entera Bio Ltd. (0001638097) (Issuer)

Other ENTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends